Supernus Pharmaceuticals, Inc.

Mirae Asset Global Investments Co., Ltd. SUPN

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/26/2026

Shares

8,090

Value ($000)

402

Weight

0.0%

2022 Q2 - 2025 Q4 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/26/2026	402	0.0%	8,090	12/31/2025
2025 Q3	11/3/2025	357	0.0%	7,472	9/30/2025
2025 Q2	7/21/2025	68	0.0%	2,163	6/30/2025
2025 Q1	4/24/2025	60	0.0%	1,868	3/31/2025
2024 Q4	1/27/2025	68	0.0%	1,840	12/31/2024
2024 Q3	10/23/2024	61	0.0%	1,993	9/30/2024
2024 Q2	7/30/2024	44	0.0%	1,641	6/30/2024
2024 Q1	5/1/2024	843	0.0%	23,279	3/31/2024
2023 Q4	1/24/2024	689	0.0%	23,809	12/31/2023
2023 Q3	10/26/2023	632	0.0%	22,937	9/30/2023
2023 Q2	8/10/2023	688	0.0%	22,886	6/30/2023
2023 Q1	5/4/2023	833	0.0%	22,987	3/31/2023
2022 Q4	2/9/2023	797	0.0%	22,335	12/31/2022
2022 Q3	11/10/2022	755	0.0%	22,302	9/30/2022
2022 Q2	8/15/2022	463	0.0%	16,039	6/30/2022